Advarra signs TransPerfect as strategic language services provider

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/cybrain)
(Image: Getty/cybrain)

Related tags: Clinical trial

Advarra has selected TransPerfect Life Sciences as its strategic supplier of language services, including document translation, digital content localization, and interpretation services.

Advarra – formed recently following the merger of Chesapeake IRB and Schulman IRB​ – provides institutional review board (IRB), institutional biosafety committee (IBC), and global research compliance services.

TransPerfect has been a long-standing partner of both IRBs prior to the merger, Jeff Wendel, Advarra president told Outsourcing-Pharma.com.

"TransPerfect uses the translation memory we’ve built over years of working together to continuously improve translation turnaround times while maintaining high levels of accuracy and quality​," Wendel explained.

"Its TransPort platform provides our staff with transparency into the process, helping us to streamline our internal workflows to meet client timelines,​" he added.

TransPerfect also recently announced that ARCA Biopharma selected its Trial Interactive eTMF solution as its enterprise platform for clinical trials. 

The CO-based biopharmaceutical company used the solution to support a Phase II trial across 50 sites, and moving forward, will transfer all trials to a paperless environment.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars